“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic
During the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. In contrast to the routine vaccine p...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bilimsel Tip Yayinevi
2021-03-01
|
Series: | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
Subjects: | |
Online Access: | http://www.floradergisi.org/managete/fu_folder/2021-01/12-22%20Berkay%20Kapar.pdf |
id |
doaj-9edb1f59b16945c98c610056a8e3c5c2 |
---|---|
record_format |
Article |
spelling |
doaj-9edb1f59b16945c98c610056a8e3c5c22021-04-15T09:15:00ZengBilimsel Tip YayineviFlora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi1300-932X1300-932X2021-03-01261122210.5578/flora.20219902“The Good, the Bad and the Ugly” in the First Year of COVID-19 PandemicBerkay Kapar0https://orcid.org/0000-0001-6458-3346Deniz Şimşek1https://orcid.org/0000-0001-5455-5667Gülay Sain Güven2https://orcid.org/0000-0001-8176-9767Department of Internal Diseases, Hacettepe University Faculty of Medicine Hospital, Ankara, TurkeyDepartment of Internal Diseases, Hacettepe University Faculty of Medicine Hospital, Ankara, TurkeyDepartment of Internal Medicine, Division of General İnternal Medicine, Hacettepe University Faculty of Medicine, Ankara, TurkeyDuring the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. In contrast to the routine vaccine production process, SARS-CoV-2 vaccines have been developed in a short period of time by many pharmaceutical companies, and community vaccination has started in many countries. However, this process is restricted by mutation and problems in production and distribution. The fact that the pathophysiology of the disease has not been fully elucidated has brought the prolonged COVID-19 syndrome definition to our clinical practice. Positive improvements and negative aspects that we have encountered so far in the first year of this new pandemic reminded us the great film by Sergio Leone: “The Good, The Bad and The Ugly”. So, we decided to cover these aspects under the same headings. Gaining an overview of the many developments, problems and solution ideas we encountered and witnessed during the pandemic year will make the management of the process easier.http://www.floradergisi.org/managete/fu_folder/2021-01/12-22%20Berkay%20Kapar.pdfcovid-19sars-cov-2novel coronavirus |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Berkay Kapar Deniz Şimşek Gülay Sain Güven |
spellingShingle |
Berkay Kapar Deniz Şimşek Gülay Sain Güven “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi covid-19 sars-cov-2 novel coronavirus |
author_facet |
Berkay Kapar Deniz Şimşek Gülay Sain Güven |
author_sort |
Berkay Kapar |
title |
“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic |
title_short |
“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic |
title_full |
“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic |
title_fullStr |
“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic |
title_full_unstemmed |
“The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic |
title_sort |
“the good, the bad and the ugly” in the first year of covid-19 pandemic |
publisher |
Bilimsel Tip Yayinevi |
series |
Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
issn |
1300-932X 1300-932X |
publishDate |
2021-03-01 |
description |
During the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. In contrast to the routine vaccine production process, SARS-CoV-2 vaccines have been developed in a short period of time by many pharmaceutical companies, and community vaccination has started in many countries. However, this process is restricted by mutation and problems in production and distribution. The fact that the pathophysiology of the disease has not been fully elucidated has brought the prolonged COVID-19 syndrome definition to our clinical practice. Positive improvements and negative aspects that we have encountered so far in the first year of this new pandemic reminded us the great film by Sergio Leone: “The Good, The Bad and The Ugly”. So, we decided to cover these aspects under the same headings. Gaining an overview of the many developments, problems and solution ideas we encountered and witnessed during the pandemic year will make the management of the process easier. |
topic |
covid-19 sars-cov-2 novel coronavirus |
url |
http://www.floradergisi.org/managete/fu_folder/2021-01/12-22%20Berkay%20Kapar.pdf |
work_keys_str_mv |
AT berkaykapar thegoodthebadandtheuglyinthefirstyearofcovid19pandemic AT denizsimsek thegoodthebadandtheuglyinthefirstyearofcovid19pandemic AT gulaysainguven thegoodthebadandtheuglyinthefirstyearofcovid19pandemic |
_version_ |
1721526458126434304 |